20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Investigating GTS-21 Powder for Schizophrenia and Nicotine Dependence Treatment

At NINGBO INNO PHARMCHEM CO.,LTD., we are continuously monitoring advancements in pharmaceutical research, particularly in areas impacting mental health and addiction. GTS-21 powder has emerged as a significant compound of interest, with ongoing investigations into its efficacy for treating challenging conditions such as schizophrenia and nicotine dependence.

Schizophrenia is a complex psychiatric disorder that affects how a person thinks, feels, and behaves. Current treatments offer symptom management but often come with significant side effects. GTS-21, as a selective u03b17 nicotinic acetylcholine receptor agonist, is being explored for its potential to address some of the core cognitive and negative symptoms of schizophrenia. Its ability to modulate neurotransmitter systems, including dopamine and glutamate, is thought to be key to its therapeutic promise in this area. Researchers are optimistic that GTS-21 powder could offer a novel therapeutic approach.

Nicotine dependence is another major public health concern. The u03b17 nAChRs are heavily involved in the reinforcing effects of nicotine. GTS-21's action at these receptors suggests it could serve as a tool to reduce nicotine withdrawal symptoms or cravings. By potentially desensitizing or modulating the u03b17 nAChR pathway, GTS-21 may help individuals reduce their reliance on nicotine. The prospect of using GTS-21 powder to aid in smoking cessation is a significant area of ongoing clinical research.

For scientists and researchers involved in these critical fields, access to high-quality GTS-21 raw powder is essential. NINGBO INNO PHARMCHEM CO.,LTD. provides a reliable source to buy GTS-21 powder online, supporting the rigorous scientific inquiry needed to bring these potential treatments to fruition. The continued study of GTS-21's pharmacodynamics and pharmacokinetics will be vital in understanding its full therapeutic potential for these complex conditions.

We believe in empowering research that can lead to significant breakthroughs in patient care. By supplying compounds like GTS-21, NINGBO INNO PHARMCHEM CO.,LTD. plays a part in the global effort to find better treatments for mental health disorders and addiction.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: GTS-21: A Deep Dive into its Alpha7 Nicotinic Receptor Agonist Properties

Next: The Neuroprotective Role of GTS-21 in Combating Neurodegenerative Diseases

All Rights Reserved